Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.

RoslinCT, a UK-based contract development and manufacturing organisation specialised in advanced cell therapies, has secured an undisclosed sum from GHO Capital Partners. The company was spun out of Roslin Institute in 2006 before the institute became a part of University of Edinburgh two years later. It does not appear to have declared any other equity…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.